Addition of Lenalidomide to Melphalan in the Treatment of Newly Diagnosed Multiple Myeloma: The NCIC CTG MY.11 Trial

  • Darrell White Queen Elizabeth II Health Sciences Centre and Dalhousie University
  • Nancy Paul National Cancer Institute of Canada Clinical Trials Group
  • David A Macdonald Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax
  • Ralph M Meyer National Cancer Institute of Canada Clinical Trials Group
How to Cite
White, D., Paul, N., Macdonald, D. A., & Meyer, R. M. (1). Addition of Lenalidomide to Melphalan in the Treatment of Newly Diagnosed Multiple Myeloma: The NCIC CTG MY.11 Trial. Current Oncology, 14(2). https://doi.org/10.3747/co.v14i2.148
Section
Medical Oncology